购物车
- 全部删除
- 您的购物车当前为空
L002 是一种细胞可渗透的,可逆特定性乙酰转移酶 p300(KAT3B)抑制剂,IC50为 1.98 μM。 它结合乙酰辅酶 A 口袋并竞争性抑制 FATp300 催化结构域,阻断组蛋白乙酰化和 p53 乙酰化,且抑制 STAT3 激活,有用于高血压引起的心脏肥大和纤维化的研究潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
L002 是一种细胞可渗透的,可逆特定性乙酰转移酶 p300(KAT3B)抑制剂,IC50为 1.98 μM。 它结合乙酰辅酶 A 口袋并竞争性抑制 FATp300 催化结构域,阻断组蛋白乙酰化和 p53 乙酰化,且抑制 STAT3 激活,有用于高血压引起的心脏肥大和纤维化的研究潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 329 | 现货 | |
2 mg | ¥ 478 | 现货 | |
5 mg | ¥ 763 | 现货 | |
10 mg | ¥ 1,130 | 现货 | |
25 mg | ¥ 2,590 | 现货 | |
50 mg | ¥ 3,860 | 现货 | |
100 mg | ¥ 5,530 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 857 | 现货 |
产品描述 | L002, a potent, cell-permeable, reversible, and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 μM, directly binds the acetyl-CoA pocket and competitively inhibits the FATp300 catalytic domain. By blocking histone acetylation, p53 acetylation, and STAT3 activation, L002 shows potential in the treatment of hypertension‐induced cardiac hypertrophy and fibrogenesis. |
靶点活性 | GCN5:34 µM , KAT3B:1.98 uM , PCAF:35 µM |
体外活性 | L002 also has weak inhibitory effects against PCAF and GCN5 (IC50s =35 and 34 μM, respectively) and is specific for p300 over a panel of deacetylases, additional acetyltransferases, and methyltransferases. |
体内活性 | L002 reverses hypertension‐induced cardiac hypertrophy and fibrosis by treatment of mice after inducing hypertension for two weeks significantly.It also reduces the levels of perivascular and interstitial collagen in the myocardium compared to non-treated hypertensive mice. |
分子量 | 321.35 |
分子式 | C15H15NO5S |
CAS No. | 321695-57-2 |
Smiles | COc1ccc(cc1)S(=O)(=O)ON=C1C=C(C)C(=O)C(C)=C1 |
密度 | 1.28 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 60 mg/mL (186.71 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容